Trajectory Of Symptom Burden, Impact And Survival In An Idiopathic Pulmonary Fibrosis Population

被引:0
|
作者
Russell, A. -M. [1 ]
Scholand, M. [2 ]
Snyder, E. A. [3 ,4 ]
Doyle, A. -M. [1 ,5 ]
Russell, A. [1 ,5 ]
Burdett, C. [1 ,5 ]
Lasky, J. [6 ]
Saketkoo, L. A. [7 ]
机构
[1] Imperial Coll, Natl Heart & Lung Inst, London, England
[2] Univ Utah, Salt Lake City, UT USA
[3] New Orleans Scleroderma & Sarcoidosis Patientt Ca, New Oleans, LA USA
[4] Tulane Univ, Lung Ctr, New Oleans, LA USA
[5] Royal Brompton & Harefield NHS Fdn Trust, London, England
[6] Tulane Univ, New Orleans, LA 70118 USA
[7] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6221
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners
    Lindell, Kathleen Oare
    Olshansky, Ellen
    Song, Mi-Kyung
    Zullo, Thomas G.
    Gibson, Kevin F.
    Kaminski, Naftali
    Hoffman, Leslie A.
    HEART & LUNG, 2010, 39 (04): : 304 - 313
  • [32] The impact of a network based approach on lung function and symptom duration at diagnosis in idiopathic pulmonary fibrosis
    Lodhi, Taha
    Leonard, Colm
    Ortega, Pilar Rivera
    Morris, Helen
    Marshall, Tracey
    Zakis, Katherine
    Garfoot, Theresa
    Hayton, Conal
    Greaves, Melanie
    Blaikley, John
    Chaudhuri, Nazia
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [33] Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden
    Lancaster, Lisa
    Bonella, Francesco
    Inoue, Yoshikazu
    Cottin, Vincent
    Siddall, James
    Small, Mark
    Langley, Jonathan
    RESPIROLOGY, 2022, 27 (01) : 66 - 75
  • [34] CONTENT VALIDITY OF TWO SYMPTOM QUESTIONNAIRES FOR IDIOPATHIC PULMONARY FIBROSIS
    Gries, K. S.
    Esser, D.
    Wiklund, I
    VALUE IN HEALTH, 2012, 15 (07) : A566 - A566
  • [35] The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis
    Fell, Charlene D.
    Martinez, Fernando J.
    CHEST, 2007, 131 (03) : 641 - 643
  • [36] Pulmonary Arterial Compliance As A Predictor Of Survival In Idiopathic Pulmonary Fibrosis
    Zouk, A. N.
    Sharif, R.
    Kulkarni, T.
    Lara, M. Acosta
    Luckhardt, T. R.
    De Andrade, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [37] Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis
    van der Plas, Mart N.
    van Kan, Coen
    Blumenthal, Judith
    Jansen, Henk M.
    Wells, Athol U.
    Bresser, Paul
    RESPIROLOGY, 2014, 19 (02) : 269 - 275
  • [38] Nintedanib for idiopathic pulmonary fibrosis in the Japanese population
    Jo, Helen E.
    Corte, Tamera J.
    RESPIROLOGY, 2017, 22 (04) : 630 - 631
  • [39] The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE Study
    Saunders, Peter
    Wu, Zhe
    Fahy, William A.
    Stewart, Iain D.
    Saini, Gauri
    Smith, David J. F.
    Braybrooke, Rebecca
    Stock, Carmel
    Renzoni, Elisabetta A.
    Johnson, Simon R.
    Jenkins, R. Gisli
    Belvisi, Maria G.
    Smith, Jaclyn A.
    Maher, Toby M.
    Molyneaux, Philip L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (09) : 1267 - 1273
  • [40] Impact of Pre-Transplantation Pulmonary Hypertension on Post-Transplant Survival in Idiopathic Pulmonary Fibrosis
    Mathai, S. C.
    Girgis, R. E.
    Shah, A.
    Hassoun, P. M.
    McDyer, J. F.
    Orens, J. B.
    Merlo, C. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179